News

Gilead joins a lineup of Big Pharma partners betting big on Tri NKE Ts with a 300 M cash ante to get started on a 5 T4

Gilead joins a lineup of Big Pharma partners betting big on TriNKETs, with a $300M cash ante to get started on a 5T4

May 2, 2022 | By LabCentral

Share :
Previous Page Next Page